UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act File Number: 811-08203
T. Rowe Price Integrated Equity Funds, Inc.
(Exact name of registrant as specified in charter)
100 East Pratt Street, Baltimore, MD 21202
(Address of principal executive offices)
David Oestreicher
100 East Pratt Street, Baltimore, MD 21202
(Name and address of agent for service)
Registrant’s telephone number, including area code: (410) 345-2000
Date of fiscal year end: December 31
Date of reporting period: June 30, 2023
Item 1. Reports to Shareholders
(a) Report pursuant to Rule 30e-1
Market
Commentary
Portfolio
Summary
Fund
Expense
Example
Financial
Highlights
Portfolio
of
Investments
Financial
Statements
and
Notes
Additional
Fund
Information
For
more
insights
from
T.
Rowe
Price
investment
professionals,
go
to
troweprice.com
.
T.
ROWE
PRICE
PRDSX
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
–
.
TQAAX
Integrated
U.S.
Small-Cap
Growth
Equity
Fund–
.
Advisor Class
TQAIX
Integrated
U.S.
Small-Cap
Growth
Equity
Fund–
.
I Class
(Formerly
T.
Rowe
Price
QM
U.S.
Small-Cap
Growth
Equity
Fund)
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Log
in
to
your
account
at
troweprice.com
for
more
information.
*
Certain
mutual
fund
accounts
that
are
assessed
an
annual
account
service
fee
can
also
save
money
by
switching
to
e-delivery.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Market
Commentary
Dear
Shareholder
Most
major
global
stock
and
bond
indexes
produced
positive
returns
during
the
first
half
of
your
fund’s
fiscal
year,
the
six-month
period
ended
June
30,
2023.
Despite
turmoil
in
the
banking
sector
and
a
protracted
debt
ceiling
standoff,
markets
were
resilient
as
growth
remained
positive
in
the
major
economies
and
corporate
earnings
results
came
in
stronger
than
expected.
For
the
six-month
period,
the
technology-oriented
Nasdaq
Composite
Index
gained
more
than
30%,
the
strongest
result
of
the
major
benchmarks,
as
tech
companies
benefited
from
investor
enthusiasm
for
artificial
intelligence
applications.
Growth
stocks
outperformed
value
shares,
and
developed
market
stocks
generally
outpaced
their
emerging
market
counterparts.
Currency
movements
were
mixed
over
the
period,
although
a
weaker
dollar
versus
major
European
currencies
was
beneficial
for
U.S.
investors
in
European
securities.
Within
the
S&P
500
Index,
the
information
technology,
communication
services,
and
consumer
discretionary
sectors
were
all
lifted
by
the
tech
rally
and
recorded
significant
gains.
Conversely,
the
defensive
utilities
sector
had
the
weakest
returns
in
the
growth-focused
environment,
and
the
energy
sector
also
lost
ground
amid
declining
oil
prices.
The
financials
sector
partly
recovered
from
the
failure
of
three
large
regional
banks
during
the
period
but
still
finished
with
modest
losses.
Cheaper
oil
contributed
to
slowing
inflation,
although
core
inflation
readings—
which
exclude
volatile
food
and
energy
prices—remained
stubbornly
high.
In
response,
the
Federal
Reserve
raised
its
short-term
lending
benchmark
rate
to
a
target
range
of
5.00%
to
5.25%
by
early
May,
the
highest
level
since
2007.
The
Fed
held
rates
steady
at
its
June
meeting,
but
policymakers
indicated
that
two
more
rate
hikes
could
come
by
the
end
of
the
year.
In
the
fixed
income
market,
returns
were
generally
positive
across
most
sectors
as
investors
benefited
from
the
higher
interest
rates
that
have
become
available
over
the
past
year.
Investment-grade
corporate
bonds
were
supported
by
generally
solid
balance
sheets
and
were
among
the
strongest
performers.
Global
economies
and
markets
showed
surprising
resilience
in
recent
months,
but,
moving
into
the
second
half
of
2023,
we
believe
investors
could
face
potential
challenges.
The
impact
of
the
Fed’s
rate
hikes
has
yet
to
be
fully
felt
in
the
economy,
and
while
the
regional
banking
turmoil
appears
to
have
been
contained
by
the
swift
actions
of
regulators,
it
could
weigh
on
credit
conditions.
Moreover,
market
consensus
still
seems
to
point
to
a
coming
recession,
although
hopes
have
emerged
that
such
a
downturn
could
be
more
modest.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
We
believe
this
environment
makes
skilled
active
management
a
critical
tool
for
identifying
risks
and
opportunities,
and
our
investment
teams
will
continue
to
use
fundamental
research
to
identify
securities
that
can
add
value
to
your
portfolio
over
the
long
term.
You
may
notice
that
this
report
no
longer
contains
the
commentary
on
your
fund’s
performance
and
positioning
that
we
previously
included
in
the
semiannual
shareholder
letters.
The
Securities
and
Exchange
Commission
(SEC)
adopted
new
rules
in
January
that
will
require
fund
reports
to
transition
to
a
new
format
known
as
a
Tailored
Shareholder
Report.
This
change
will
require
a
much
more
concise
summary
of
performance
rather
than
the
level
of
detail
we
have
provided
historically
while
also
aiming
to
be
more
visually
engaging.
As
we
prepare
to
make
changes
to
the
annual
reports
to
meet
the
new
report
regulatory
requirements
by
mid-2024,
we
felt
the
time
was
right
to
discontinue
the
optional
six-month
semiannual
fund
letter
to
focus
on
the
changes
to
come.
While
semiannual
fund
letters
will
no
longer
be
produced,
you
may
continue
to
access
current
fund
information
as
well
as
insights
and
perspectives
from
our
investment
team
on
our
personal
investing
website.
Thank
you
for
your
continued
confidence
in
T.
Rowe
Price.
Sincerely,
Robert
Sharps
CEO
and
President
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Portfolio
Summary
SECTOR
DIVERSIFICATION
As
of
6/30/23
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
MSCI
US
Small
Cap
Growth
Index
Health
Care
23.5%
22.8%
Industrials
and
Business
Services
22.4
21.5
Information
Technology
18.8
18.6
Consumer
Discretionary
12.7
13.5
Financials
5.2
6.2
Energy
4.4
4.5
Consumer
Staples
4.3
3.7
Materials
4.0
4.2
Communication
Services
2.7
3.1
Real
Estate
0.8
1.2
Utilities
0.6
0.7
Other
and
Reserves
0.6
0.0
Total
100.0%
100.0%
Based
on
net
assets
as
of
6/30/23.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
PORTFOLIO
HIGHLIGHTS
TWENTY-FIVE
LARGEST
HOLDINGS
Percent
of
Net
Assets
6/30/23
Manhattan
Associates
1.0%
Saia
1.0
Casella
Waste
Systems
0.9
SPS
Commerce
0.9
Axcelis
Technologies
0.8
EMCOR
Group
0.8
Comfort
Systems
USA
0.8
Churchill
Downs
0.8
Ensign
Group
0.8
Builders
FirstSource
0.8
Novanta
0.8
TechnipFMC
0.8
Super
Micro
Computer
0.8
Inspire
Medical
Systems
0.8
CACI
International
0.8
Curtiss-Wright
0.7
Texas
Roadhouse
0.7
World
Wrestling
Entertainment
0.7
Atkore
0.7
Medpace
Holdings
0.7
Iridium
Communications
0.7
UFP
Industries
0.7
Fair
Isaac
0.7
Murphy
USA
0.7
Fabrinet
0.7
Total
19.6%
Note:
The
information
shown
does
not
reflect
any
exchange-traded
funds
(ETFs),
cash
reserves,
or
collateral
for
securities
lending
that
may
be
held
in
the
portfolio.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
FUND
EXPENSE
EXAMPLE
As
a
mutual
fund
shareholder,
you
may
incur
two
types
of
costs:
(1)
transaction
costs,
such
as
redemption
fees
or
sales
loads,
and
(2)
ongoing
costs,
including
management
fees,
distribution
and
service
(12b-1)
fees,
and
other
fund
expenses.
The
following
example
is
intended
to
help
you
understand
your
ongoing
costs
(in
dollars)
of
investing
in
the
fund
and
to
compare
these
costs
with
the
ongoing
costs
of
investing
in
other
mutual
funds.
The
example
is
based
on
an
investment
of
$1,000
invested
at
the
beginning
of
the
most
recent
six-month
period
and
held
for
the
entire
period.
Please
note
that
the
fund
has
three
share
classes:
The
original
share
class
(Investor
Class)
charges
no
distribution
and
service
(12b-1)
fee,
the
Advisor
Class
shares
are
offered
only
through
unaffiliated
brokers
and
other
financial
intermediaries
and
charge
a
0.25%
12b-1
fee,
and
I
Class
shares
are
available
to
institutionally
oriented
clients
and
impose
no
12b-1
or
administrative
fee
payment.
Each
share
class
is
presented
separately
in
the
table.
Actual
Expenses
The
first
line
of
the
following
table
(Actual)
provides
information
about
actual
account
values
and
expenses
based
on
the
fund’s
actual
returns.
You
may
use
the
information
on
this
line,
together
with
your
account
balance,
to
estimate
the
expenses
that
you
paid
over
the
period.
Simply
divide
your
account
value
by
$1,000
(for
example,
an
$8,600
account
value
divided
by
$1,000
=
8.6),
then
multiply
the
result
by
the
number
on
the
first
line
under
the
heading
“Expenses
Paid
During
Period”
to
estimate
the
expenses
you
paid
on
your
account
during
this
period.
Hypothetical
Example
for
Comparison
Purposes
The
information
on
the
second
line
of
the
table
(Hypothetical)
is
based
on
hypothetical
account
values
and
expenses
derived
from
the
fund’s
actual
expense
ratio
and
an
assumed
5%
per
year
rate
of
return
before
expenses
(not
the
fund’s
actual
return).
You
may
compare
the
ongoing
costs
of
investing
in
the
fund
with
other
funds
by
contrasting
this
5%
hypothetical
example
and
the
5%
hypothetical
examples
that
appear
in
the
shareholder
reports
of
the
other
funds.
The
hypothetical
account
values
and
expenses
may
not
be
used
to
estimate
the
actual
ending
account
balance
or
expenses
you
paid
for
the
period.
Note:
T.
Rowe
Price
charges
an
annual
account
service
fee
of
$20,
generally
for
accounts
with
less
than
$10,000.
The
fee
is
waived
for
any
investor
whose
T.
Rowe
Price
mutual
fund
accounts
total
$50,000
or
more;
accounts
electing
to
receive
electronic
delivery
of
account
statements,
transaction
confirmations,
prospectuses,
and
shareholder
reports;
or
accounts
of
an
investor
who
is
a
T.
Rowe
Price
Personal
Services
or
Enhanced
Personal
Services
client
(enrollment
in
these
programs
generally
requires
T.
Rowe
Price
assets
of
at
least
$250,000).
This
fee
is
not
included
in
the
accompanying
table.
If
you
are
subject
to
the
fee,
keep
it
in
mind
when
you
are
estimating
the
ongoing
expenses
of
investing
in
the
fund
and
when
comparing
the
expenses
of
this
fund
with
other
funds.
You
should
also
be
aware
that
the
expenses
shown
in
the
table
highlight
only
your
ongoing
costs
and
do
not
reflect
any
transaction
costs,
such
as
redemption
fees
or
sales
loads.
Therefore,
the
second
line
of
the
table
is
useful
in
comparing
ongoing
costs
only
and
will
not
help
you
determine
the
relative
total
costs
of
owning
different
funds.
To
the
extent
a
fund
charges
transaction
costs,
however,
the
total
cost
of
owning
that
fund
is
higher.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
INTEGRATED
U.S.
SMALL-CAP
GROWTH
EQUITY
FUND
Beginning
Account
Value
1/1/23
Ending
Account
Value
6/30/23
Expenses
Paid
During
Period*
1/1/23
to
6/30/23
Investor
Class
Actual
$1,000.00
$1,139.90
$4.24
Hypothetical
(assumes
5%
return
before
expenses)
1,000.00
1,020.83
4.01
Advisor
Class
Actual
1,000.00
1,138.30
5.78
Hypothetical
(assumes
5%
return
before
expenses)
1,000.00
1,019.39
5.46
I
Class
Actual
1,000.00
1,140.90
3.50
Hypothetical
(assumes
5%
return
before
expenses)
1,000.00
1,021.52
3.31
*
Expenses
are
equal
to
the
fund’s
annualized
expense
ratio
for
the
6-month
period,
multiplied
by
the
average
account
value
over
the
period,
multiplied
by
the
number
of
days
in
the
most
recent
fiscal
half
year
(181),
and
divided
by
the
days
in
the
year
(365)
to
reflect
the
half-year
period.
The
annualized
expense
ratio
of
the
1
Investor
Class
was
0.80%,
the
2
Advisor Class
was
1.09%,
and
the
3
I Class
was
0.66%.
FUND
EXPENSE
EXAMPLE
(CONTINUED)
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
For
a
share
outstanding
throughout
each
period
Investor
Class
6
Months
.
Ended
6/30/23
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
NET
ASSET
VALUE
Beginning
of
period
$
34
.68
$
46
.35
$
47
.73
$
39
.70
$
31
.16
$
34
.89
Investment
activities
Net
investment
loss
(1)(2)
(
0
.05
)
(
0
.09
)
(
0
.20
)
(
0
.09
)
(
0
.06
)
(
0
.08
)
Net
realized
and
unrealized
gain/loss
4
.90
(
10
.29
)
5
.30
9
.51
10
.24
(
2
.24
)
Total
from
investment
activities
4
.85
(
10
.38
)
5
.10
9
.42
10
.18
(
2
.32
)
Distributions
Net
realized
gain
—
(
1
.29
)
(
6
.48
)
(
1
.39
)
(
1
.64
)
(
1
.41
)
NET
ASSET
VALUE
End
of
period
$
39
.53
$
34
.68
$
46
.35
$
47
.73
$
39
.70
$
31
.16
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Investor
Class
6
Months
.
Ended
6/30/23
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
Ratios/Supplemental
Data
Total
return
(2)(3)
13
.99
%
(
22
.41
)
%
11
.30
%
23
.84
%
32
.76
%
(
6
.86
)
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
0
.80
%
(4)
0
.80
%
0
.78
%
0
.78
%
0
.79
%
0
.80
%
Net
expenses
after
waivers/payments
by
Price
Associates
0
.80
%
(4)
0
.80
%
0
.78
%
0
.78
%
0
.79
%
0
.80
%
Net
investment
loss
(
0
.29
)
%
(4)
(
0
.25
)
%
(
0
.40
)
%
(
0
.23
)
%
(
0
.16
)
%
(
0
.22
)
%
Portfolio
turnover
rate
15
.4
%
30
.3
%
28
.3
%
34
.5
%
21
.6
%
17
.9
%
Net
assets,
end
of
period
(in
millions)
$3,822
$3,354
$5,524
$5,747
$5,254
$4,039
0
%
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(4)
Annualized
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
For
a
share
outstanding
throughout
each
period
Advisor
Class
6
Months
.
Ended
6/30/23
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
NET
ASSET
VALUE
Beginning
of
period
$
34
.20
$
45
.86
$
47
.43
$
39
.48
$
31
.10
$
34
.79
Investment
activities
Net
investment
loss
(1)(2)
(
0
.11
)
(
0
.19
)
(
0
.36
)
(
0
.21
)
(
0
.18
)
(
0
.18
)
Net
realized
and
unrealized
gain/loss
4
.84
(
10
.18
)
5
.27
9
.42
10
.20
(
2
.23
)
Total
from
investment
activities
4
.73
(
10
.37
)
4
.91
9
.21
10
.02
(
2
.41
)
Distributions
Net
realized
gain
—
(
1
.29
)
(
6
.48
)
(
1
.26
)
(
1
.64
)
(
1
.29
)
...
....
....
....
....
....
....
Redemption
fees
added
to
paid-in
capital
(1)(3)
—
—
—
—
—
(4)
0
.01
NET
ASSET
VALUE
End
of
period
$
38
.93
$
34
.20
$
45
.86
$
47
.43
$
39
.48
$
31
.10
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Advisor
Class
6
Months
.
Ended
6/30/23
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
Ratios/Supplemental
Data
Total
return
(2)(5)
13
.83
%
(
22
.63
)
%
10
.97
%
23
.43
%
32
.30
%
(
7
.09
)
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
1
.09
%
(6)
1
.08
%
1
.09
%
1
.10
%
1
.11
%
1
.07
%
Net
expenses
after
waivers/payments
by
Price
Associates
1
.09
%
(6)
1
.08
%
1
.09
%
1
.10
%
1
.11
%
1
.07
%
Net
investment
loss
(
0
.59
)
%
(6)
(
0
.52
)
%
(
0
.71
)
%
(
0
.55
)
%
(
0
.49
)
%
(
0
.49
)
%
Portfolio
turnover
rate
15
.4
%
30
.3
%
28
.3
%
34
.5
%
21
.6
%
17
.9
%
Net
assets,
end
of
period
(in
thousands)
$15,054
$17,483
$28,195
$32,629
$24,781
$24,430
0
%
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
The
fund
charged
redemption
fees
through
March
31,
2019.
(4)
Amounts
round
to
less
than
$0.01
per
share.
(5)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(6)
Annualized
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
For
a
share
outstanding
throughout
each
period
I
Class
6
Months
.
Ended
6/30/23
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
NET
ASSET
VALUE
Beginning
of
period
$
34
.93
$
46
.61
$
47
.89
$
39
.82
$
31
.21
$
34
.94
Investment
activities
Net
investment
loss
(1)(2)
(
0
.03
)
(
0
.03
)
(
0
.13
)
(
0
.04
)
(
0
.01
)
(
0
.02
)
Net
realized
and
unrealized
gain/loss
4
.95
(
10
.36
)
5
.33
9
.55
10
.26
(
2
.25
)
Total
from
investment
activities
4
.92
(
10
.39
)
5
.20
9
.51
10
.25
(
2
.27
)
Distributions
Net
realized
gain
—
(
1
.29
)
(
6
.48
)
(
1
.44
)
(
1
.64
)
(
1
.46
)
NET
ASSET
VALUE
End
of
period
$
39
.85
$
34
.93
$
46
.61
$
47
.89
$
39
.82
$
31
.21
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
For
a
share
outstanding
throughout
each
period
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
I
Class
6
Months
.
Ended
6/30/23
..
Year
..
..
Ended
.
12/31/22
12/31/21
12/31/20
12/31/19
12/31/18
Ratios/Supplemental
Data
Total
return
(2)(3)
14
.09
%
(
22
.31
)
%
11
.47
%
24
.00
%
32
.93
%
(
6
.72
)
%
Ratios
to
average
net
assets:
(2)
Gross
expenses
before
waivers/
payments
by
Price
Associates
0
.66
%
(4)
0
.66
%
0
.64
%
0
.65
%
0
.65
%
0
.66
%
Net
expenses
after
waivers/payments
by
Price
Associates
0
.66
%
(4)
0
.66
%
0
.64
%
0
.65
%
0
.65
%
0
.66
%
Net
investment
loss
(
0
.15
)
%
(4)
(
0
.09
)
%
(
0
.26
)
%
(
0
.10
)
%
(
0
.02
)
%
(
0
.06
)
%
Portfolio
turnover
rate
15
.4
%
30
.3
%
28
.3
%
34
.5
%
21
.6
%
17
.9
%
Net
assets,
end
of
period
(in
millions)
$3,805
$3,259
$4,246
$4,317
$3,303
$2,380
0
%
0
%
0
%
0
%
0
%
0
%
(1)
Per
share
amounts
calculated
using
average
shares
outstanding
method.
(2)
See
Note
6
for
details
of
expense-related
arrangements
with
Price
Associates.
(3)
Total
return
reflects
the
rate
that
an
investor
would
have
earned
on
an
investment
in
the
fund
during
each
period,
assuming
reinvestment
of
all
distributions,
and
payment
of
no
redemption
or
account
fees,
if
applicable.
Total
return
is
not
annualized
for
periods
less
than
one
year.
(4)
Annualized
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
June
30,
2023
(Unaudited)
Shares
$
Value
(Cost
and
value
in
$000s)
‡
COMMON
STOCKS
99.4%
COMMUNICATION
SERVICES
2.6%
Diversified
Telecommunication
Services
0.7%
Cogent
Communications
Holdings
56,500
3,802
GCI
Liberty,
Class
A,
EC (1)(2)
547,999
—
Iridium
Communications
854,100
53,057
56,859
Entertainment
1.1%
Endeavor
Group
Holdings,
Class
A (2)
1,217,900
29,132
World
Wrestling
Entertainment,
Class
A
513,000
55,645
84,777
Interactive
Media
&
Services
0.1%
Ziff
Davis (2)
57,640
4,038
4,038
Media
0.7%
Nexstar
Media
Group
289,100
48,149
Thryv
Holdings (2)
309,500
7,614
55,763
Total
Communication
Services
201,437
CONSUMER
DISCRETIONARY
12.7%
Automobile
Components
0.5%
LCI
Industries
39,700
5,016
Patrick
Industries
105,250
8,420
Visteon (2)
175,500
25,204
38,640
Distributors
0.4%
Pool
82,600
30,945
30,945
Diversified
Consumer
Services
0.6%
Bright
Horizons
Family
Solutions (2)
83,854
7,752
Carriage
Services
143,300
4,653
Grand
Canyon
Education (2)
304,000
31,376
43,781
Hotels,
Restaurants
&
Leisure
5.7%
Bloomin'
Brands
679,800
18,280
Boyd
Gaming
705,400
48,934
Cava
Group (2)
124,054
5,080
Choice
Hotels
International (3)
369,000
43,365
Churchill
Downs
437,480
60,884
Domino's
Pizza
75,087
25,303
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Everi
Holdings (2)
906,900
13,114
Hilton
Grand
Vacations (2)
491,100
22,315
Papa
John's
International
77,700
5,736
Planet
Fitness,
Class
A (2)
376,600
25,398
Red
Rock
Resorts,
Class
A
553,700
25,902
SeaWorld
Entertainment (2)
242,900
13,605
Texas
Roadhouse
500,800
56,230
Travel
+
Leisure
349,000
14,079
Vail
Resorts
74,030
18,638
Wendy's
1,888,200
41,068
437,931
Household
Durables
1.6%
Cavco
Industries (2)
76,714
22,631
Skyline
Champion (2)
346,900
22,705
Tempur
Sealy
International
793,600
31,799
TopBuild (2)
157,800
41,978
119,113
Leisure
Products
0.6%
Brunswick
124,340
10,773
Mattel (2)
1,811,000
35,387
46,160
Specialty
Retail
2.4%
Academy
Sports
&
Outdoors
390,700
21,117
Asbury
Automotive
Group (2)
70,400
16,926
Burlington
Stores (2)
60,300
9,491
Dick's
Sporting
Goods
211,300
27,932
Floor
&
Decor
Holdings,
Class
A (2)
14,300
1,487
Murphy
USA
165,700
51,551
Penske
Automotive
Group
97,800
16,296
Valvoline
1,025,500
38,466
183,266
Textiles,
Apparel
&
Luxury
Goods
0.9%
Crocs (2)
302,900
34,058
Deckers
Outdoor (2)
68,100
35,934
69,992
Total
Consumer
Discretionary
969,828
CONSUMER
STAPLES
4.3%
Beverages
0.4%
Coca-Cola
Consolidated
51,700
32,882
32,882
Consumer
Staples
Distribution
&
Retail
0.9%
BJ's
Wholesale
Club
Holdings (2)
234,700
14,789
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Casey's
General
Stores
76,900
18,754
Performance
Food
Group (2)
532,700
32,090
65,633
Food
Products
1.3%
Darling
Ingredients (2)
65,700
4,191
Hostess
Brands (2)
799,900
20,253
Post
Holdings (2)
508,800
44,088
Simply
Good
Foods (2)
834,000
30,516
99,048
Personal
Care
Products
1.7%
BellRing
Brands (2)
834,900
30,557
Coty,
Class
A (2)
2,017,900
24,800
elf
Beauty (2)
277,500
31,699
Inter
Parfums
314,300
42,503
129,559
Total
Consumer
Staples
327,122
ENERGY
4.4%
Energy
Equipment
&
Services
1.9%
ChampionX
751,700
23,333
Nabors
Industries (2)
41,800
3,889
TechnipFMC (2)
3,512,500
58,378
Transocean (2)(3)
2,257,400
15,824
Weatherford
International (2)
668,000
44,368
145,792
Oil,
Gas
&
Consumable
Fuels
2.5%
APA
248,200
8,481
Centrus
Energy,
Class
A (2)
128,300
4,177
Denbury (2)
235,100
20,280
Kosmos
Energy (2)
2,879,800
17,250
Magnolia
Oil
&
Gas,
Class
A
1,051,300
21,972
Matador
Resources
603,100
31,554
PBF
Energy,
Class
A
140,300
5,744
PDC
Energy
172,400
12,265
Range
Resources
1,247,300
36,671
SM
Energy
604,400
19,117
Southwestern
Energy (2)
782,000
4,700
Targa
Resources
137,700
10,479
192,690
Total
Energy
338,482
FINANCIALS
5.2%
Banks
0.4%
Bancorp (2)
771,500
25,190
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
ServisFirst
Bancshares (3)
161,300
6,600
31,790
Capital
Markets
1.7%
Blue
Owl
Capital
1,654,100
19,270
FactSet
Research
Systems
62,100
24,881
LPL
Financial
Holdings
193,800
42,138
MarketAxess
Holdings
92,900
24,286
StoneX
Group (2)
208,800
17,347
127,922
Financial
Services
0.9%
Euronet
Worldwide (2)
212,700
24,964
EVERTEC
358,100
13,189
Shift4
Payments,
Class
A (2)(3)
434,900
29,534
67,687
Insurance
2.2%
BRP
Group,
Class
A (2)
336,500
8,338
Kinsale
Capital
Group
91,600
34,277
Palomar
Holdings (2)
356,280
20,678
Primerica
193,000
38,168
Ryan
Specialty
Holdings,
Class
A (2)
771,700
34,642
Selective
Insurance
Group
371,600
35,655
171,758
Total
Financials
399,157
HEALTH
CARE
23.6%
Biotechnology
9.1%
ACADIA
Pharmaceuticals (2)
785,812
18,820
Agios
Pharmaceuticals (2)
290,281
8,221
Akero
Therapeutics (2)
316,656
14,785
Alector (2)
294,326
1,769
Alkermes (2)
1,027,900
32,173
Allogene
Therapeutics (2)
365,301
1,816
Amicus
Therapeutics (2)
940,700
11,815
Apellis
Pharmaceuticals (2)
470,430
42,856
Arcellx (2)
104,000
3,289
Avidity
Biosciences (2)
420,774
4,666
Biohaven (2)
461,750
11,045
Biomea
Fusion (2)
103,900
2,281
Blueprint
Medicines (2)
409,085
25,854
C4
Therapeutics (2)
75,400
207
Catalyst
Pharmaceuticals (2)
800,500
10,759
Cerevel
Therapeutics
Holdings (2)(3)
420,500
13,368
CRISPR
Therapeutics (2)(3)
351,358
19,725
Cytokinetics (2)(3)
389,700
12,712
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Day
One
Biopharmaceuticals (2)(3)
223,020
2,663
Denali
Therapeutics (2)
404,200
11,928
Exelixis (2)
1,552,500
29,668
Generation
Bio (2)
422,600
2,324
Halozyme
Therapeutics (2)
1,175,300
42,393
Horizon
Therapeutics (2)
143,692
14,779
Ideaya
Biosciences (2)
76,018
1,786
IGM
Biosciences (2)(3)
143,152
1,321
ImmunoGen (2)
586,200
11,062
Insmed (2)
1,124,693
23,731
Intellia
Therapeutics (2)
333,296
13,592
Ionis
Pharmaceuticals (2)
641,100
26,304
Iovance
Biotherapeutics (2)
908,758
6,398
Karuna
Therapeutics (2)
164,450
35,661
Krystal
Biotech (2)
59,400
6,974
Kymera
Therapeutics (2)
289,000
6,644
Madrigal
Pharmaceuticals (2)
37,100
8,570
Mirati
Therapeutics (2)
170,097
6,146
Monte
Rosa
Therapeutics (2)
65,000
445
Morphic
Holding (2)
179,526
10,292
Natera (2)
494,900
24,082
Neurocrine
Biosciences (2)
191,326
18,042
Nurix
Therapeutics (2)
149,800
1,497
Prothena (2)
308,630
21,073
PTC
Therapeutics (2)
456,100
18,550
Relay
Therapeutics (2)
448,200
5,629
Replimune
Group (2)
468,666
10,883
REVOLUTION
Medicines (2)
465,092
12,441
Rhythm
Pharmaceuticals (2)
150,100
2,475
Rocket
Pharmaceuticals (2)
286,029
5,683
Sage
Therapeutics (2)
250,959
11,800
Scholar
Rock
Holding (2)
377,651
2,848
Scholar
Rock
Holding,
Warrants,
12/31/25,
Acquisition
Date:
6/17/22,
Cost $— (2)(4)
22,712
88
Seagen (2)
104,200
20,054
Ultragenyx
Pharmaceutical (2)
304,141
14,030
Vaxcyte (2)
214,300
10,702
Xencor (2)
468,800
11,706
Zentalis
Pharmaceuticals (2)
158,711
4,477
694,902
Health
Care
Equipment
&
Supplies
5.9%
AtriCure (2)
304,500
15,030
CONMED
211,100
28,686
Embecta
284,300
6,141
Globus
Medical,
Class
A (2)
628,700
37,433
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Haemonetics (2)
358,700
30,540
ICU
Medical (2)
100,898
17,979
Inari
Medical (2)
299,000
17,384
Inspire
Medical
Systems (2)
177,400
57,591
iRhythm
Technologies (2)
187,400
19,550
Lantheus
Holdings (2)
584,200
49,026
Merit
Medical
Systems (2)
574,500
48,051
Omnicell (2)
284,000
20,922
Penumbra (2)
90,800
31,241
PROCEPT
BioRobotics (2)
351,300
12,418
Shockwave
Medical (2)
79,999
22,833
STERIS
145,866
32,817
447,642
Health
Care
Providers
&
Services
4.1%
Acadia
Healthcare (2)
151,400
12,058
Addus
HomeCare (2)
281,800
26,123
Amedisys (2)
141,700
12,957
AMN
Healthcare
Services (2)
458,300
50,010
Chemed
22,200
12,025
CorVel (2)
164,966
31,921
Ensign
Group
637,000
60,808
Guardant
Health (2)
547,264
19,592
ModivCare (2)
74,100
3,350
Molina
Healthcare (2)
157,400
47,415
NeoGenomics (2)
394,600
6,341
Option
Care
Health (2)
908,351
29,512
312,112
Health
Care
Technology
0.2%
Evolent
Health,
Class
A (2)
599,000
18,150
18,150
Life
Sciences
Tools
&
Services
2.7%
10X
Genomics,
Class
A (2)
415,400
23,196
Adaptive
Biotechnologies (2)
407,100
2,732
Bruker
205,600
15,198
Charles
River
Laboratories
International (2)
132,700
27,900
Maravai
LifeSciences
Holdings,
Class
A (2)
689,100
8,566
Medpace
Holdings (2)
230,900
55,455
Olink
Holding,
ADR (2)
268,656
5,037
Repligen (2)
190,900
27,005
West
Pharmaceutical
Services
98,400
37,635
202,724
Pharmaceuticals
1.6%
Amphastar
Pharmaceuticals (2)
375,800
21,597
Arvinas (2)
248,265
6,162
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Catalent (2)
247,041
10,712
Intra-Cellular
Therapies (2)
451,000
28,557
Pacira
BioSciences (2)
260,100
10,422
Pliant
Therapeutics (2)(3)
191,918
3,478
Prestige
Consumer
Healthcare (2)
265,800
15,796
Supernus
Pharmaceuticals (2)
353,100
10,614
Ventyx
Biosciences (2)
369,900
12,133
119,471
Total
Health
Care
1,795,001
INDUSTRIALS
&
BUSINESS
SERVICES
22.4%
Aerospace
&
Defense
1.6%
Cadre
Holdings
235,500
5,134
Curtiss-Wright
308,300
56,622
Hexcel
421,000
32,004
Leonardo
DRS (2)(3)
853,400
14,798
Mercury
Systems (2)
119,100
4,120
Moog,
Class
A
114,200
12,383
125,061
Air
Freight
&
Logistics
0.5%
GXO
Logistics (2)
606,700
38,113
38,113
Building
Products
2.4%
AAON
259,500
24,603
Builders
FirstSource (2)
444,700
60,479
CSW
Industrials
179,000
29,748
Gibraltar
Industries (2)
108,100
6,802
Simpson
Manufacturing
44,200
6,122
UFP
Industries
539,800
52,387
180,141
Commercial
Services
&
Supplies
2.3%
Casella
Waste
Systems,
Class
A (2)
800,500
72,405
Clean
Harbors (2)
312,400
51,368
MSA
Safety
107,700
18,736
Rentokil
Initial,
ADR
863,760
33,695
176,204
Construction
&
Engineering
2.1%
Comfort
Systems
USA
371,900
61,066
EMCOR
Group
335,700
62,031
WillScot
Mobile
Mini
Holdings (2)
781,200
37,333
160,430
Electrical
Equipment
1.1%
Array
Technologies (2)
583,900
13,196
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Atkore (2)
356,343
55,568
Shoals
Technologies
Group,
Class
A (2)
748,300
19,127
87,891
Ground
Transportation
2.1%
Landstar
System
164,900
31,750
RXO (2)
455,500
10,326
Saia (2)
216,300
74,063
XPO (2)
753,200
44,439
160,578
Machinery
4.3%
Albany
International,
Class
A
167,000
15,578
Federal
Signal
523,800
33,539
Graco
76,410
6,598
John
Bean
Technologies
275,700
33,442
Kadant
174,400
38,734
Lincoln
Electric
Holdings
177,600
35,276
RBC
Bearings (2)
182,025
39,585
SPX
Technologies (2)
436,400
37,081
Symbotic (2)
270,500
11,580
Toro
295,600
30,048
Watts
Water
Technologies,
Class
A
244,700
44,959
326,420
Professional
Services
4.7%
ASGN (2)
86,600
6,550
Booz
Allen
Hamilton
Holding
403,100
44,986
Broadridge
Financial
Solutions
116,500
19,296
CACI
International,
Class
A (2)
168,700
57,500
CBIZ (2)
642,200
34,216
Concentrix
74,700
6,032
ExlService
Holdings (2)
318,600
48,128
Exponent
447,816
41,790
Insperity
318,200
37,853
NV5
Global (2)
133,700
14,810
Paylocity
Holding (2)
140,800
25,982
SS&C
Technologies
Holdings
140,800
8,532
Verra
Mobility (2)
756,800
14,924
360,599
Trading
Companies
&
Distributors
1.3%
Herc
Holdings
110,600
15,136
McGrath
RentCorp
183,056
16,929
SiteOne
Landscape
Supply (2)
220,100
36,836
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Watsco (3)
75,000
28,610
97,511
Total
Industrials
&
Business
Services
1,712,948
INFORMATION
TECHNOLOGY
18.7%
Communications
Equipment
0.4%
Extreme
Networks (2)
614,000
15,995
Lumentum
Holdings (2)(3)
212,700
12,066
28,061
Electronic
Equipment,
Instruments
&
Components
2.7%
Advanced
Energy
Industries
255,500
28,476
Fabrinet (2)
396,800
51,536
Littelfuse
64,700
18,848
Novanta (2)
327,900
60,366
Teledyne
Technologies (2)
73,530
30,229
Zebra
Technologies,
Class
A (2)
54,600
16,152
205,607
IT
Services
0.5%
Gartner (2)
45,900
16,079
Perficient (2)
309,700
25,807
41,886
Semiconductors
&
Semiconductor
Equipment
5.3%
Axcelis
Technologies (2)
350,100
64,184
Cirrus
Logic (2)
241,130
19,534
Diodes (2)
377,700
34,933
Entegris
134,600
14,916
FormFactor (2)
470,600
16,104
Kulicke
&
Soffa
Industries
419,000
24,910
Lattice
Semiconductor (2)
525,000
50,437
MaxLinear (2)
676,600
21,354
MKS
Instruments
118,500
12,810
Monolithic
Power
Systems
42,007
22,693
Onto
Innovation (2)
365,600
42,581
Power
Integrations
431,100
40,812
Rambus (2)
486,700
31,232
Synaptics (2)
122,000
10,416
406,916
Software
8.7%
A10
Networks
788,200
11,500
ACI
Worldwide (2)
496,900
11,513
Agilysys (2)
232,200
15,938
Aspen
Technology (2)
48,076
8,058
Blackbaud (2)
241,200
17,169
Box,
Class
A (2)
1,051,200
30,884
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
Descartes
Systems
Group (2)
637,300
51,054
Digital
Turbine (2)
176,200
1,635
DoubleVerify
Holdings (2)
879,251
34,221
Envestnet (2)
338,100
20,066
Fair
Isaac (2)
64,500
52,194
Fortinet (2)
270,700
20,462
Informatica,
Class
A (2)
774,400
14,326
Manhattan
Associates (2)
401,000
80,152
NCR (2)
583,200
14,697
PowerSchool
Holdings,
Class
A (2)(3)
855,200
16,369
PTC (2)
224,250
31,911
Qualys (2)
278,500
35,974
Rapid7 (2)
314,900
14,259
Sapiens
International
687,900
18,298
SPS
Commerce (2)
351,500
67,509
Tenable
Holdings (2)
518,400
22,576
Teradata (2)
477,400
25,498
Tyler
Technologies (2)
72,400
30,152
Workiva (2)
219,900
22,355
668,770
Technology
Hardware,
Storage
&
Peripherals
1.1%
Pure
Storage,
Class
A (2)
725,800
26,724
Super
Micro
Computer (2)
232,800
58,025
84,749
Total
Information
Technology
1,435,989
MATERIALS
4.0%
Chemicals
1.4%
Axalta
Coating
Systems (2)
1,013,200
33,243
Balchem
121,100
16,325
Element
Solutions
684,100
13,135
Livent (2)(3)
898,600
24,649
Olin
452,500
23,254
110,606
Construction
Materials
0.6%
Eagle
Materials
247,900
46,213
46,213
Containers
&
Packaging
0.7%
Graphic
Packaging
Holding
1,440,100
34,606
Silgan
Holdings
322,100
15,103
49,709
Metals
&
Mining
0.8%
Alpha
Metallurgical
Resources
42,500
6,985
Arconic (2)
256,400
7,584
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
ATI (2)
779,200
34,464
Royal
Gold
124,000
14,233
63,266
Paper
&
Forest
Products
0.5%
Louisiana-Pacific
505,800
37,925
37,925
Total
Materials
307,719
REAL
ESTATE
0.9%
Industrial
Real
Estate
Investment
Trusts
0.7%
First
Industrial
Realty
Trust,
REIT
409,700
21,567
Rexford
Industrial
Realty,
REIT
309,500
16,162
Terreno
Realty,
REIT
203,100
12,206
49,935
Residential
Real
Estate
Investment
Trusts
0.2%
Equity
LifeStyle
Properties,
REIT
205,400
13,739
13,739
Total
Real
Estate
63,674
UTILITIES
0.6%
Independent
Power
&
Renewable
Electricity
Producers
0.6%
Clearway
Energy,
Class
C
416,800
11,904
NextEra
Energy
Partners (3)
282,000
16,537
Ormat
Technologies
181,300
14,587
Total
Utilities
43,028
Total
Common
Stocks
(Cost
$5,332,141)
7,594,385
SHORT-TERM
INVESTMENTS
0.9%
Money
Market
Funds
0.9%
T.
Rowe
Price
Government
Reserve
Fund,
5.13% (5)(6)
69,797,827
69,798
Total
Short-Term
Investments
(Cost
$69,798)
69,798
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Shares
$
Value
(Cost
and
value
in
$000s)
‡
SECURITIES
LENDING
COLLATERAL
1.4%
INVESTMENTS
IN
A
POOLED
ACCOUNT
THROUGH
SECURITIES
LENDING
PROGRAM
WITH
STATE
STREET
BANK
AND
TRUST
COMPANY
1.4%
Money
Market
Funds
1.4%
T.
Rowe
Price
Government
Reserve
Fund,
5.13% (5)(6)
107,336,577
107,337
Total
Investments
in
a
Pooled
Account
through
Securities
Lending
Program
with
State
Street
Bank
and
Trust
Company
107,337
Total
Securities
Lending
Collateral
(Cost
$107,337)
107,337
Total
Investments
in
Securities
101.7%
of
Net
Assets
(Cost
$5,509,276)
$
7,771,520
‡
Shares
are
denominated
in
U.S.
dollars
unless
otherwise
noted.
(1)
See
Note
2.
Level
3
in
fair
value
hierarchy.
(2)
Non-income
producing
(3)
See
Note
3.
All
or
a
portion
of
this
security
is
on
loan
at
June
30,
2023.
(4)
Security
cannot
be
offered
for
public
resale
without
first
being
registered
under
the
Securities
Act
of
1933
and
related
rules
("restricted
security").
Acquisition
date
represents
the
day
on
which
an
enforceable
right
to
acquire
such
security
is
obtained
and
is
presented
along
with
related
cost
in
the
security
description.
The
fund
may
have
registration
rights
for
certain
restricted
securities.
Any
costs
related
to
such
registration
are
generally
borne
by
the
issuer.
The
aggregate
value
of
restricted
securities
(excluding
144A
holdings)
at
period
end
amounts
to
$88
and
represents
0.0%
of
net
assets.
(5)
Seven-day
yield
(6)
Affiliated
Companies
ADR
American
Depositary
Receipts
EC
Escrow
CUSIP;
represents
a
beneficial
interest
in
a
residual
pool
of
assets;
the
amount
and
timing
of
future
distributions,
if
any,
is
uncertain;
when
presented,
interest
rate
and
maturity
date
are
those
of
the
original
security.
REIT
A
domestic
Real
Estate
Investment
Trust
whose
distributions
pass-through
with
original
tax
character
to
the
shareholder
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
AFFILIATED
COMPANIES
($000s)
The
fund
may
invest
in
certain
securities
that
are
considered
affiliated
companies.
As
defined
by
the
1940
Act,
an
affiliated
company
is
one
in
which
the
fund
owns
5%
or
more
of
the
outstanding
voting
securities,
or
a
company
that
is
under
common
ownership
or
control.
The
following
securities
were
considered
affiliated
companies
for
all
or
some
portion
of
the
six
months
ended
June
30,
2023.
Net
realized
gain
(loss),
investment
income,
change
in
net
unrealized
gain/loss,
and
purchase
and
sales
cost
reflect
all
activity
for
the
period
then
ended.
Affiliate
Net
Realized
Gain
(Loss)
Change
in
Net
Unrealized
Gain/Loss
Investment
Income
T.
Rowe
Price
Government
Reserve
Fund,
5.13%
$
—
$
—
$
1,628++
Totals
$
—#
$
—
$
1,628+
Supplementary
Investment
Schedule
Affiliate
Value
12/31/22
Purchase
Cost
Sales
Cost
Value
06/30/23
T.
Rowe
Price
Government
Reserve
Fund,
5.13%
$
105,019
¤
¤
$
177,135
Total
$
177,135^
#
Capital
gain
distributions
from
underlying
Price
funds
represented
$0
of
the
net
realized
gain
(loss).
++
Excludes
earnings
on
securities
lending
collateral,
which
are
subject
to
rebates
and
fees
as
described
in
Note
3.
+
Investment
income
comprised
$1,628
of
dividend
income
and
$0
of
interest
income.
¤
Purchase
and
sale
information
not
shown
for
cash
management
funds.
^
The
cost
basis
of
investments
in
affiliated
companies
was
$177,135.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
June
30,
2023
(Unaudited)
Statement
of
Assets
and
Liabilities
($000s,
except
shares
and
per
share
amounts)
Assets
Investments
in
securities,
at
value
(cost
$5,509,276)
$
7,771,520
Receivable
for
investment
securities
sold
13,818
Receivable
for
shares
sold
7,550
Dividends
receivable
1,594
Other
assets
145
Total
assets
7,794,627
Liabilities
Obligation
to
return
securities
lending
collateral
107,337
Payable
for
investment
securities
purchased
33,821
Payable
for
shares
redeemed
5,494
Investment
management
fees
payable
3,870
Due
to
affiliates
96
Payable
to
directors
6
Other
liabilities
1,147
Total
liabilities
151,771
NET
ASSETS
$
7,642,856
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
June
30,
2023
(Unaudited)
Statement
of
Assets
and
Liabilities
($000s,
except
shares
and
per
share
amounts)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Net
Assets
Consist
of:
Total
distributable
earnings
(loss)
$
2,331,426
Paid-in
capital
applicable
to
192,567,530
shares
of
$0.0001
par
value
capital
stock
outstanding;
1,000,000,000
shares
authorized
5,311,430
NET
ASSETS
$
7,642,856
NET
ASSET
VALUE
PER
SHARE
Investor
Class
(Net
assets:
$3,822,357;
Shares
outstanding:
96,685,423)
$
39.53
Advisor
Class
(Net
assets:
$15,054;
Shares
outstanding:
386,690)
$
38.93
I
Class
(Net
assets:
$3,805,445;
Shares
outstanding:
95,495,417)
$
39.85
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
6
Months
Ended
6/30/23
Investment
Income
(Loss)
Income
Dividend
(net
of
foreign
taxes
of
$45)
$
18,047
Securities
lending
73
Other
1
Total
income
18,121
Expenses
Investment
management
22,593
Shareholder
servicing
Investor
Class
$
2,402
Advisor
Class
12
I
Class
75
2,489
Rule
12b-1
fees
Advisor
Class
22
Prospectus
and
shareholder
reports
Investor
Class
261
Advisor
Class
4
I
Class
138
403
Proxy
and
annual
meeting
186
Custody
and
accounting
144
Registration
59
Legal
and
audit
15
Directors
12
Miscellaneous
21
Total
expenses
25,944
Net
investment
loss
(7,823)
Realized
and
Unrealized
Gain
/
Loss
–
Net
realized
gain
on
securities
48,828
Change
in
net
unrealized
gain
/
loss
on
securities
890,075
Net
realized
and
unrealized
gain
/
loss
938,903
INCREASE
IN
NET
ASSETS
FROM
OPERATIONS
$
931,080
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
Statement
of
Changes
in
Net
Assets
6
Months
Ended
6/30/23
Year
Ended
12/31/22
Increase
(Decrease)
in
Net
Assets
Operations
Net
investment
loss
$
(7,823)
$
(12,742)
Net
realized
gain
48,828
159,530
Change
in
net
unrealized
gain
/
loss
890,075
(2,282,935)
Increase
(decrease)
in
net
assets
from
operations
931,080
(2,136,147)
Distributions
to
shareholders
Net
earnings
Investor
Class
–
(122,439)
Advisor
Class
–
(636)
I
Class
–
(117,304)
Decrease
in
net
assets
from
distributions
–
(240,379)
Capital
share
transactions
*
Shares
sold
Investor
Class
393,542
608,257
Advisor
Class
1,309
2,866
I
Class
365,154
1,149,059
Distributions
reinvested
Investor
Class
–
115,243
Advisor
Class
–
636
I
Class
–
110,347
Shares
redeemed
Investor
Class
(390,073)
(1,583,159)
Advisor
Class
(5,810)
(7,822)
I
Class
(282,570)
(1,186,327)
Increase
(decrease)
in
net
assets
from
capital
share
transactions
81,552
(790,900)
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(Unaudited)
Statement
of
Changes
in
Net
Assets
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
6
Months
Ended
6/30/23
Year
Ended
12/31/22
Net
Assets
Increase
(decrease)
during
period
1,012,632
(3,167,426)
Beginning
of
period
6,630,224
9,797,650
End
of
period
$
7,642,856
$
6,630,224
*Share
information
(000s)
Shares
sold
Investor
Class
10,465
15,895
Advisor
Class
36
75
I
Class
9,755
30,274
Distributions
reinvested
Investor
Class
–
3,295
Advisor
Class
–
18
I
Class
–
3,132
Shares
redeemed
Investor
Class
(10,492)
(41,650)
Advisor
Class
(160)
(197)
I
Class
(7,545)
(31,224)
Increase
(decrease)
in
shares
outstanding
2,059
(20,382)
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Unaudited
NOTES
TO
FINANCIAL
STATEMENTS
T.
Rowe
Price
Integrated
Equity
Funds,
Inc.
(the
corporation),
formerly
the
Quantitative
Management
Funds,
Inc., is
registered
under
the
Investment
Company
Act
of
1940
(the
1940
Act).
The
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
(the
fund),
formerly
the
T.
Rowe
Price
QM
U.S.
Small-Cap
Growth
Equity
Fund,
is a
diversified, open-
end
management
investment
company
established
by
the
corporation. The
fund
seeks
long-term
growth
of
capital
by
investing
primarily
in
common
stocks
of
small
growth
companies.
The
fund
has
three classes
of
shares:
the
Integrated
U.S.
Small-
Cap
Growth
Equity
Fund
(Investor
Class),
the
Integrated
U.S.
Small-Cap
Growth
Equity
Fund–Advisor
Class
(Advisor
Class)
and
the
Integrated
U.S.
Small-Cap
Growth
Equity
Fund–I
Class
(I
Class).
Advisor
Class
shares
are
sold
only
through
various
brokers
and
other
financial
intermediaries.
I
Class
shares
require
a
$500,000
initial
investment
minimum,
although
the
minimum
generally
is
waived
or
reduced
for
financial
intermediaries,
eligible
retirement
plans,
and
certain
other
accounts.
The
Advisor
Class
operates
under
a
Board-approved
Rule
12b-1
plan
pursuant
to
which
the
class
compensates
financial
intermediaries
for
distribution,
shareholder
servicing,
and/
or
certain
administrative
services;
the
Investor
and
I
Classes
do
not
pay
Rule
12b-1
fees. Each
class
has
exclusive
voting
rights
on
matters
related
solely
to
that
class;
separate
voting
rights
on
matters
that
relate
to
all classes;
and,
in
all
other
respects,
the
same
rights
and
obligations
as
the
other
classes.
NOTE
1
-
SIGNIFICANT
ACCOUNTING
POLICIES
Basis
of
Preparation
The fund
is
an
investment
company
and
follows
accounting
and
reporting
guidance
in
the
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946
(ASC
946).
The
accompanying
financial
statements
were
prepared
in
accordance
with
accounting
principles
generally
accepted
in
the
United
States
of
America
(GAAP),
including,
but
not
limited
to,
ASC
946.
GAAP
requires
the
use
of
estimates
made
by
management.
Management
believes
that
estimates
and
valuations
are
appropriate;
however,
actual
results
may
differ
from
those
estimates,
and
the
valuations
reflected
in
the
accompanying
financial
statements
may
differ
from
the
value
ultimately
realized
upon
sale
or
maturity.
Investment
Transactions,
Investment
Income,
and
Distributions
Investment
transactions
are
accounted
for
on
the
trade
date
basis.
Income
and
expenses
are
recorded
on
the
accrual
basis.
Realized
gains
and
losses
are
reported
on
the
identified
cost
basis.
Income
tax-related
interest
and
penalties,
if
incurred,
are
recorded
as
income
tax
expense.
Dividends
received
from other
investment
companies are
reflected
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
as
dividend
income;
capital
gain
distributions
are
reflected
as
realized
gain/loss.
Dividend
income and
capital
gain
distributions
are
recorded
on
the
ex-dividend
date.
Distributions
from
REITs
are
initially
recorded
as
dividend
income
and,
to
the
extent
such
represent
a
return
of
capital
or
capital
gain
for
tax
purposes,
are
reclassified
when
such
information
becomes
available.
Non-cash
dividends,
if
any,
are
recorded
at
the
fair
market
value
of
the
asset
received.
Proceeds
from
litigation
payments,
if
any,
are
included
in
either
net
realized
gain
(loss)
or
change
in
net
unrealized
gain/loss
from
securities.
Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date.
Income
distributions,
if
any,
are
declared
and
paid
by
each
class annually.
A
capital
gain
distribution,
if
any, may
also
be
declared
and
paid
by
the
fund
annually.
Class
Accounting
Shareholder
servicing,
prospectus,
and
shareholder
report
expenses
incurred
by
each
class
are
charged
directly
to
the
class
to
which
they
relate.
Expenses
common
to
all
classes,
investment
income,
and
realized
and
unrealized
gains
and
losses
are
allocated
to
the
classes
based
upon
the
relative
daily
net
assets
of
each
class.
The
Advisor
Class
pays
Rule
12b-1
fees,
in
an
amount
not
exceeding
0.25%
of
the
class’s
average
daily
net
assets.
Capital
Transactions
Each
investor’s
interest
in
the
net
assets
of the
fund
is
represented
by
fund
shares. The
fund’s
net
asset
value
(NAV)
per
share
is
computed
at
the
close
of
the
New
York
Stock
Exchange
(NYSE),
normally
4
p.m.
ET,
each
day
the
NYSE
is
open
for
business.
However,
the
NAV
per
share
may
be
calculated
at
a
time
other
than
the
normal
close
of
the
NYSE
if
trading
on
the
NYSE
is
restricted,
if
the
NYSE
closes
earlier,
or
as
may
be
permitted
by
the
SEC.
Purchases
and
redemptions
of
fund
shares
are
transacted
at
the
next-computed
NAV
per
share,
after
receipt
of
the
transaction
order
by
T.
Rowe
Price
Associates,
Inc.,
or
its
agents.
New
Accounting
Guidance
In
June
2022,
the
FASB
issued
Accounting
Standards
Update
(ASU),
ASU
2022-03,
Fair
Value
Measurement
(Topic
820)
–
Fair
Value
Measurement
of
Equity
Securities
Subject
to
Contractual
Sale
Restrictions,
which
clarifies
that
a
contractual
restriction
on
the
sale
of
an
equity
security
is
not
considered
part
of
the
unit
of
account
of
the
equity
security
and,
therefore,
is
not
considered
in
measuring
fair
value.
The
amendments
under
this
ASU
are
effective
for
fiscal
years
beginning
after
December
15,
2023;
however,
the
fund
opted
to
early
adopt,
as
permitted,
effective
December
1,
2022. Adoption
of
the
guidance
did not
have
a
material
impact
on
the fund's
financial statements.
Indemnification
In
the
normal
course
of
business, the
fund
may
provide
indemnification
in
connection
with
its
officers
and
directors,
service
providers,
and/or
private
company
investments. The
fund’s
maximum
exposure
under
these
arrangements
is
unknown;
however,
the
risk
of
material
loss
is
currently
considered
to
be
remote.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
NOTE
2
-
VALUATION
Fair
Value
The
fund’s
financial
instruments
are
valued
at
the
close
of
the
NYSE
and
are
reported
at
fair
value,
which
GAAP
defines
as
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
at
the
measurement
date. The fund’s
Board
of
Directors
(the
Board)
has
designated
T.
Rowe
Price
Associates,
Inc.
as
the
fund’s
valuation
designee
(Valuation
Designee).
Subject
to
oversight
by
the
Board,
the
Valuation
Designee
performs
the
following
functions
in
performing
fair
value
determinations:
assesses
and
manages
valuation
risks;
establishes
and
applies
fair
value
methodologies;
tests
fair
value
methodologies;
and
evaluates
pricing
vendors
and
pricing
agents.
The
duties
and
responsibilities
of
the
Valuation
Designee
are
performed
by
its
Valuation
Committee. The
Valuation
Designee provides
periodic
reporting
to
the
Board
on
valuation
matters.
Various
valuation
techniques
and
inputs
are
used
to
determine
the
fair
value
of
financial
instruments.
GAAP
establishes
the
following
fair
value
hierarchy
that
categorizes
the
inputs
used
to
measure
fair
value:
Level
1
–
quoted
prices
(unadjusted)
in
active
markets
for
identical
financial
instruments
that
the
fund
can
access
at
the
reporting
date
Level
2
–
inputs
other
than
Level
1
quoted
prices
that
are
observable,
either
directly
or
indirectly
(including,
but
not
limited
to,
quoted
prices
for
similar
financial
instruments
in
active
markets,
quoted
prices
for
identical
or
similar
financial
instruments
in
inactive
markets,
interest
rates
and
yield
curves,
implied
volatilities,
and
credit
spreads)
Level
3
–
unobservable
inputs
(including
the Valuation
Designee’s assumptions
in
determining
fair
value)
Observable
inputs
are
developed
using
market
data,
such
as
publicly
available
information
about
actual
events
or
transactions,
and
reflect
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
Unobservable
inputs
are
those
for
which
market
data
are
not
available
and
are
developed
using
the
best
information
available
about
the
assumptions
that
market
participants
would
use
to
price
the
financial
instrument.
GAAP
requires
valuation
techniques
to
maximize
the
use
of
relevant
observable
inputs
and
minimize
the
use
of
unobservable
inputs.
When
multiple
inputs
are
used
to
derive
fair
value,
the
financial
instrument
is
assigned
to
the
level
within
the
fair
value
hierarchy
based
on
the
lowest-level
input
that
is
significant
to
the
fair
value
of
the
financial
instrument.
Input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level
but
rather
the
degree
of
judgment
used
in
determining
those
values.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Valuation
Techniques
Equity
securities,
including
exchange-traded
funds, listed
or
regularly
traded
on
a
securities
exchange
or
in
the
over-the-counter
(OTC)
market
are
valued
at
the
last
quoted
sale
price
or,
for
certain
markets,
the
official
closing
price
at
the
time
the
valuations
are
made.
OTC
Bulletin
Board
securities
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices.
A
security
that
is
listed
or
traded
on
more
than
one
exchange
is
valued
at
the
quotation
on
the
exchange
determined
to
be
the
primary
market
for
such
security.
Listed
securities
not
traded
on
a
particular
day
are
valued
at
the
mean
of
the
closing
bid
and
asked
prices
for
domestic
securities.
Investments
in
mutual
funds
are
valued
at
the
mutual
fund’s
closing
NAV
per
share
on
the
day
of
valuation.
Assets
and
liabilities
other
than
financial
instruments,
including
short-term
receivables
and
payables,
are
carried
at
cost,
or
estimated
realizable
value,
if
less,
which
approximates
fair
value.
Investments
for
which
market
quotations are
not
readily
available
or
deemed
unreliable
are
valued
at
fair
value
as
determined
in
good
faith
by
the
Valuation
Designee.
The
Valuation
Designee
has
adopted
methodologies
for
determining
the
fair
value
of
investments
for
which
market
quotations
are
not
readily
available
or
deemed
unreliable,
including
the
use
of
other
pricing
sources.
Factors
used
in
determining
fair
value
vary
by
type
of
investment
and
may
include
market
or
investment
specific
considerations.
The
Valuation
Designee typically
will
afford
greatest
weight
to
actual
prices
in
arm’s
length
transactions,
to
the
extent
they
represent
orderly
transactions
between
market
participants,
transaction
information
can
be
reliably
obtained,
and
prices
are
deemed
representative
of
fair
value.
However,
the
Valuation
Designee may
also
consider
other
valuation
methods
such
as
market-based
valuation
multiples;
a
discount
or
premium
from
market
value
of
a
similar,
freely
traded
security
of
the
same
issuer;
discounted
cash
flows;
yield
to
maturity;
or
some
combination.
Fair
value
determinations
are
reviewed
on
a
regular
basis.
Because
any
fair
value
determination
involves
a
significant
amount
of
judgment,
there
is
a
degree
of
subjectivity
inherent
in
such
pricing
decisions. Fair
value
prices
determined
by
the
Valuation
Designee could
differ
from
those
of
other
market
participants,
and
it
is
possible
that
the
fair
value
determined
for
a
security
may
be
materially
different
from
the
value
that
could
be
realized
upon
the
sale
of
that
security.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
Valuation
Inputs
The
following
table
summarizes
the
fund’s
financial
instruments,
based
on
the
inputs
used
to
determine
their
fair
values
on
June
30,
2023
(for
further
detail
by
category,
please
refer
to
the
accompanying
Portfolio
of
Investments):
NOTE
3
-
OTHER
INVESTMENT
TRANSACTIONS
Consistent
with
its
investment
objective,
the
fund
engages
in
the
following
practices
to
manage
exposure
to
certain
risks
and/or
to
enhance
performance.
The
investment
objective,
policies,
program,
and
risk
factors
of
the
fund
are
described
more
fully
in
the
fund's
prospectus
and
Statement
of
Additional
Information.
Restricted
Securities
The
fund
invests
in
securities
that
are
subject
to
legal
or
contractual
restrictions
on
resale.
Prompt
sale
of
such
securities
at
an
acceptable
price
may
be
difficult
and
may
involve
substantial
delays
and
additional
costs.
Securities
Lending
The fund
may
lend
its
securities
to
approved
borrowers
to
earn
additional
income.
Its
securities
lending
activities
are
administered
by
a
lending
agent
in
accordance
with
a
securities
lending
agreement.
Security
loans
generally
do
not
have
stated
maturity
dates,
and
the
fund
may
recall
a
security
at
any
time.
The
fund
receives
collateral
in
the
form
of
cash
or
U.S.
government
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
the
value
of
loaned
securities;
any
additional
collateral
required
due
to
changes
in
security
values
is
delivered
to
the
fund
the
next
business
day.
Cash
collateral
is
invested
in
accordance
with
investment
guidelines
approved
by
fund
management.
Additionally,
the
lending
agent
indemnifies
the
fund
against
losses
resulting
from
borrower
default.
Although
risk
is
mitigated
by
the
collateral
and
indemnification,
the
fund
could
experience
a
delay
in
recovering
its
securities
and
a
possible
loss
of
income
or
value
if
the
borrower
fails
to
return
the
securities,
collateral
investments
decline
in
value,
and
the
lending
agent
fails
to
perform.
Securities
lending
revenue
consists
of
earnings
on
invested
collateral
and
borrowing
fees,
net
of
any
rebates
to
the
borrower,
compensation
to
the
lending
agent,
($000s)
Level
1
Level
2
Level
3
Total
Value
Assets
Common
Stocks
$
7,594,297
$
88
$
—
$
7,594,385
Short-Term
Investments
69,798
—
—
69,798
Securities
Lending
Collateral
107,337
—
—
107,337
Total
$
7,771,432
$
88
$
—
$
7,771,520
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
and
other
administrative
costs.
In
accordance
with
GAAP,
investments
made
with
cash
collateral
are
reflected
in
the
accompanying
financial
statements,
but
collateral
received
in
the
form
of
securities
is
not.
At
June
30,
2023,
the
value
of
loaned
securities
was
$104,009,000;
the
value
of
cash
collateral
and
related
investments
was
$107,337,000.
Other
Purchases
and
sales
of
portfolio
securities
other
than
short-term securities
aggregated $1,174,536,000 and
$1,093,672,000,
respectively,
for
the
six
months ended
June
30,
2023.
NOTE
4
-
FEDERAL
INCOME
TAXES
Generally,
no
provision
for
federal
income
taxes
is
required
since
the
fund
intends
to
continue
to
qualify
as
a
regulated
investment
company
under
Subchapter
M
of
the
Internal
Revenue
Code
and
distribute
to
shareholders
all
of
its
taxable
income
and
gains.
Distributions
determined
in
accordance
with
federal
income
tax
regulations
may
differ
in
amount
or
character
from
net
investment
income
and
realized
gains
for
financial
reporting
purposes.
Financial
reporting
records
are
adjusted
for
permanent
book/
tax
differences
to
reflect
tax
character
but
are
not
adjusted
for
temporary
differences.
The
amount
and
character
of
tax-basis
distributions
and
composition
of
net
assets
are
finalized
at
fiscal
year-end;
accordingly,
tax-basis
balances
have
not
been
determined
as
of
the
date
of
this
report.
At
June
30,
2023,
the
cost
of
investments
(including
derivatives,
if
any)
for
federal
income
tax
purposes
was
$5,517,637,000.
Net
unrealized
gain
aggregated
$2,253,883,000
at
period-end,
of
which $2,644,714,000
related
to
appreciated
investments
and $390,831,000
related
to
depreciated
investments.
NOTE
5
-
FOREIGN TAXES
The
fund
is
subject
to
foreign
income
taxes
imposed
by
certain
countries
in
which
it
invests.
Additionally,
capital
gains
realized
upon
disposition
of
securities
issued
in
or
by
certain
foreign
countries
are
subject
to
capital
gains
tax
imposed
by
those
countries.
All
taxes
are
computed
in
accordance
with
the
applicable
foreign
tax
law,
and,
to
the
extent
permitted,
capital
losses
are
used
to
offset
capital
gains.
Taxes
attributable
to
income
are
accrued
by
the
fund
as
a
reduction
of
income.
Current
and
deferred
tax
expense
attributable
to
capital
gains
is
reflected
as
a
component
of
realized
or
change
in
unrealized
gain/loss
on
securities
in
the
accompanying
financial
statements.
To
the
extent
that
the
fund
has
country
specific
capital
loss
carryforwards,
such
carryforwards
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
are
applied
against
net
unrealized
gains
when
determining
the
deferred
tax
liability.
Any
deferred
tax
liability
incurred
by
the
fund
is
included
in
either
Other
liabilities
or
Deferred
tax
liability
on
the
accompanying
Statement
of
Assets
and
Liabilities.
NOTE
6
-
RELATED
PARTY
TRANSACTIONS
The
fund
is
managed
by
T.
Rowe
Price
Associates,
Inc.
(Price
Associates),
a
wholly
owned
subsidiary
of
T.
Rowe
Price
Group,
Inc.
(Price
Group).
The
investment
management
agreement
between
the
fund
and
Price
Associates
provides
for
an
annual
investment
management
fee,
which
is
computed
daily
and
paid
monthly. The
fee
consists
of
an
individual
fund
fee,
equal
to
0.35%
of
the
fund’s
average
daily
net
assets,
and
a
group
fee.
The
group
fee
rate
is
calculated
based
on
the
combined
net
assets
of
certain
mutual
funds
sponsored
by
Price
Associates
(the
group)
applied
to
a
graduated
fee
schedule,
with
rates
ranging
from
0.48%
for
the
first
$1
billion
of
assets
to
0.260%
for
assets
in
excess
of
$845
billion.
The
fund’s
group
fee
is
determined
by
applying
the
group
fee
rate
to
the
fund’s
average
daily
net
assets. At
June
30,
2023,
the
effective
annual
group
fee
rate
was
0.29%.
Effective
June
1,
2023,
the Advisor Class
is
subject
to
a
contractual
expense
limitation
through
the
expense
limitation
date
indicated
in
the
table
below.
During
the
limitation
period,
Price
Associates
was
required
to
waive
its
management
fee
or
pay
any
expenses
(excluding
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage;
non-recurring,
extraordinary
expenses;
and
acquired
fund
fees
and
expenses)
that
would
otherwise
cause
the
class’s
ratio
of
annualized
total
expenses
to
average
net
assets
(net
expense
ratio)
to
exceed
its
expense
limitation.
Each
class
is
required
to
repay
Price
Associates
for
expenses
previously
waived/paid
to
the
extent
the
class’s
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class’s
net
expense
ratio
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
expense
limitation
in
place
at
the
time
such
amounts
were
waived;
or
(2)
the
class’s
current
expense
limitation.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
The
I
Class
is
also
subject
to
an
operating
expense
limitation
(I
Class
Limit)
pursuant
to
which
Price
Associates
is
contractually
required
to
pay
all
operating
expenses
of
the
I
Class,
excluding
management
fees;
interest;
expenses
related
to
borrowings,
taxes,
and
brokerage; non-recurring,
extraordinary expenses; and
acquired
fund
fees
and
expenses, to
the
extent
such
operating
expenses,
on
an
annualized
basis,
exceed
the
I
Class
Limit. This
agreement
will
continue
through
the
expense
limitation
date
indicated
in
the
table
below,
and
may
be
renewed,
revised,
or
revoked
only
with
approval
of
the
fund’s
Board.
The
I
Class
is
required
to
repay
Price
Associates
for
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
expenses
previously
paid
to
the
extent
the
class’s
net
assets
grow
or
expenses
decline
sufficiently
to
allow
repayment
without
causing
the
class’s
operating
expenses
(after
the
repayment
is
taken
into
account)
to
exceed
the
lesser
of:
(1)
the
I
Class
Limit
in
place
at
the
time
such
amounts
were
paid;
or
(2)
the
current
I
Class
Limit.
However,
no
repayment
will
be
made
more
than
three
years
after
the
date
of
a
payment
or
waiver.
In
addition,
the
fund
has
entered
into
service
agreements
with
Price
Associates
and
two
wholly
owned
subsidiaries
of
Price
Associates,
each
an
affiliate
of
the
fund
(collectively,
Price).
Price
Associates
provides
certain
accounting
and
administrative
services
to
the
fund.
T.
Rowe
Price
Services,
Inc.
provides
shareholder
and
administrative
services
in
its
capacity
as
the
fund’s
transfer
and
dividend-disbursing
agent.
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
provides
subaccounting
and
recordkeeping
services
for
certain
retirement
accounts
invested
in
the
Investor
Class
and
Advisor
Class.
For
the
six
months
ended
June
30,
2023,
expenses
incurred
pursuant
to
these
service
agreements
were
$58,000
for
Price
Associates;
$458,000
for
T.
Rowe
Price
Services,
Inc.;
and
$66,000
for
T.
Rowe
Price
Retirement
Plan
Services,
Inc.
All
amounts
due
to
and
due
from
Price,
exclusive
of
investment
management
fees
payable,
are
presented
net
on
the
accompanying
Statement
of
Assets
and
Liabilities.
The fund
may
invest
its
cash
reserves
in
certain
open-end
management
investment
companies
managed
by
Price
Associates
and
considered
affiliates
of
the
fund:
the
T.
Rowe
Price
Government
Reserve
Fund
or
the
T.
Rowe
Price
Treasury
Reserve
Fund,
organized
as
money
market
funds
(together,
the
Price
Reserve
Funds).
The
Price
Reserve
Funds
are
offered
as
short-term
investment
options
to
mutual
funds,
trusts,
and
other
accounts
managed
by
Price
Associates
or
its
affiliates
and
are
not
available
for
direct
purchase
by
members
of
the
public.
Cash
collateral
from
securities
lending,
if
any,
is
invested
in
the
T.
Rowe
Price
Government
Reserve Fund. The
Price
Reserve
Funds
pay
no
investment
management
fees.
The
fund may
participate
in
securities
purchase
and
sale
transactions
with
other
funds
or
accounts
advised
by
Price
Associates
(cross
trades),
in
accordance
with
procedures
adopted
by the
fund’s
Board
and
Securities
and
Exchange
Commission
rules,
which
require,
among
other
things,
that
such
purchase
and
sale
cross
trades
be
effected
at
the
Advisor
Class
I
Class
Expense
limitation/I
Class
Limit
1.24%
0.05%
Expense
limitation
date
04/30/24
04/30/24
(Waived)/repaid
during
the
period
($000s)
$—
$—
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
independent
current
market
price
of
the
security.
During
the
six
months
ended
June
30,
2023,
the
fund
had
no
purchases
or
sales
cross
trades
with
other
funds
or
accounts
advised
by
Price
Associates.
Price
Associates
has
voluntarily
agreed
to
reimburse
the
fund
from
its
own
resources
on
a
monthly
basis
for
the
cost
of
investment
research
embedded
in
the
cost
of
the
fund’s
securities
trades.
This
agreement
may
be
rescinded
at
any
time.
For
the
six
months ended
June
30,
2023,
this
reimbursement
amounted
to
$155,000,
which
is
included
in
Net
realized
gain
(loss)
on
Securities
in
the
Statement
of
Operations.
NOTE
7
-
OTHER
MATTERS
Unpredictable
events
such
as
environmental
or
natural
disasters,
war,
terrorism,
pandemics,
outbreaks
of
infectious
diseases,
and
similar
public
health
threats
may
significantly
affect
the
economy
and
the
markets
and
issuers
in
which
the fund
invests.
Certain
events
may
cause
instability
across
global
markets,
including
reduced
liquidity
and
disruptions
in
trading
markets,
while
some
events
may
affect
certain
geographic
regions,
countries,
sectors,
and
industries
more
significantly
than
others,
and
exacerbate
other
pre-existing
political,
social,
and
economic
risks.
Since
2020,
a
novel
strain
of
coronavirus
(COVID-19)
has
resulted
in
disruptions
to
global
business
activity
and
caused
significant
volatility
and
declines
in
global
financial
markets.
In
February
2022,
Russian
forces
entered
Ukraine
and
commenced
an
armed
conflict
leading
to
economic
sanctions
being
imposed
on
Russia
and
certain
of
its
citizens,
creating
impacts
on
Russian-related
stocks
and
debt
and
greater
volatility
in
global
markets.
In
March
2023,
the
collapse
of
some
US
regional
and
global
banks
as
well
as
overall
concerns
around
the
soundness
and
stability
of
the
global
banking
sector
has
sparked
concerns
of
a
broader
financial
crisis
impacting
the
overall
global
banking
sector.
In
certain
cases,
government
agencies
have
assumed
control
or
otherwise
intervened
in
the
operations
of
certain
banks
due
to
liquidity
and
solvency
concerns.
The
extent
of
impact
of
these
events
on
the
US
and
global
markets
is
highly
uncertain.
These
are
recent
examples
of
global
events
which
may
have
a
negative
impact
on
the
values
of
certain
portfolio
holdings
or
the
fund’s
overall
performance.
Management
is
actively
monitoring
the
risks
and
financial
impacts
arising
from
these
events.
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
INFORMATION
ON
PROXY
VOTING
POLICIES,
PROCEDURES,
AND
RECORDS
A
description
of
the
policies
and
procedures
used
by
T.
Rowe
Price
funds
to
determine
how
to
vote
proxies
relating
to
portfolio
securities
is
available
in
each
fund’s
Statement
of
Additional
Information.
You
may
request
this
document
by
calling
1-800-225-5132
or
by
accessing
the
SEC’s
website,
sec.gov.
The
description
of
our
proxy
voting
policies
and
procedures
is
also
available
on
our
corporate
website.
To
access
it,
please
visit
the
following
Web
page:
https://www.troweprice.com/corporate/us/en/utility/policies.html
Scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Guidelines.”
Click
on
the
links
in
the
shaded
box.
Each
fund’s
most
recent
annual
proxy
voting
record
is
available
on
our
website
and
through
the
SEC’s
website.
To
access
it
through
T.
Rowe
Price,
visit
the
website
location
shown
above,
and
scroll
down
to
the
section
near
the
bottom
of
the
page
that
says,
“Proxy
Voting
Records.”
Click
on
the
Proxy
Voting
Records
link
in
the
shaded
box.
RESULTS
OF
PROXY
VOTING
A
Special
Meeting
of
Shareholders
was
held
on
July
24,
2023
for
shareholders
of
record
on
April
7,
2023,
to
elect
the
following
director-nominees
to
serve
on
the
Board
of
all
Price
Funds.
The
newly
elected
Directors
took
office
effective
July
24,
2023.
The
results
of
the
voting
were
as
follows:
Teresa
Bryce
Bazemore,
Bruce
W.
Duncan,
Robert
J.
Gerrard,
Jr.,
Paul
F.
McBride
and
David
Oestreicher
continue
to
serve
as
Directors
on
the
Board
of
all
Price
Funds.
HOW
TO
OBTAIN
QUARTERLY
PORTFOLIO
HOLDINGS
The
fund
files
a
complete
schedule
of
portfolio
holdings
with
the
Securities
and
Exchange
Commission
(SEC)
for
the
first
and
third
quarters
of
each
fiscal
year
as
an
exhibit
to
its
reports
on
Form
N-PORT.
The
fund’s
reports
on
Form
N-PORT
are
available
electronically
on
the
SEC’s
website
(sec.gov).
In
addition,
most
T.
Rowe
Price
funds
disclose
their
first
and
third
fiscal
quarter-end
holdings
on
troweprice.com
.
Votes
For
Votes
Withheld
Melody
Bianchetto
128,354,769
779,465
Mark
J.
Parrell
128,220,853
904,678
Kellye
L.
Walker
128,373,209
779,665
Eric
L.
Veiel
128,442,156
698,251
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
Each
year,
the
fund’s
Board
of
Directors
(Board)
considers
the
continuation
of
the
investment
management
agreement
(Advisory
Contract)
between
the
fund
and
its
investment
adviser,
T.
Rowe
Price
Associates,
Inc.
(Adviser).
In
that
regard,
at
a
meeting
held
on
March
6–7,
2023
(Meeting),
the
Board,
including
all
of
the
fund’s
independent
directors,
approved
the
continuation
of
the
fund’s
Advisory
Contract.
At
the
Meeting,
the
Board
considered
the
factors
and
reached
the
conclusions
described
below
relating
to
the
selection
of
the
Adviser
and
the
approval
of
the
Advisory
Contract.
The
independent
directors
were
assisted
in
their
evaluation
of
the
Advisory
Contract
by
independent
legal
counsel
from
whom
they
received
separate
legal
advice
and
with
whom
they
met
separately.
In
providing
information
to
the
Board,
the
Adviser
was
guided
by
a
detailed
set
of
requests
for
information
submitted
by
independent
legal
counsel
on
behalf
of
the
independent
directors.
In
considering
and
approving
the
continuation
of
the
Advisory
Contract,
the
Board
considered
the
information
it
believed
was
relevant,
including,
but
not
limited
to,
the
information
discussed
below.
The
Board
considered
not
only
the
specific
information
presented
in
connection
with
the
Meeting
but
also
the
knowledge
gained
over
time
through
interaction
with
the
Adviser
about
various
topics.
The
Board
meets
regularly
and,
at
each
of
its
meetings,
covers
an
extensive
agenda
of
topics
and
materials
and
considers
factors
that
are
relevant
to
its
annual
consideration
of
the
renewal
of
the
T.
Rowe
Price
funds’
advisory
contracts,
including
performance
and
the
services
and
support
provided
to
the
funds
and
their
shareholders.
Services
Provided
by
the
Adviser
The
Board
considered
the
nature,
quality,
and
extent
of
the
services
provided
to
the
fund
by
the
Adviser.
These
services
included,
but
were
not
limited
to,
directing
the
fund’s
investments
in
accordance
with
its
investment
program
and
the
overall
management
of
the
fund’s
portfolio,
as
well
as
a
variety
of
related
activities
such
as
financial,
investment
operations,
and
administrative
services;
compliance;
maintaining
the
fund’s
records
and
registrations;
and
shareholder
communications.
The
Board
also
reviewed
the
background
and
experience
of
the
Adviser’s
senior
management
team
and
investment
personnel
involved
in
the
management
of
the
fund,
as
well
as
the
Adviser’s
compliance
record.
The
Board
concluded
that
the
information
it
considered
with
respect
to
the
nature,
quality,
and
extent
of
the
services
provided
by
the
Adviser,
as
well
as
the
other
factors
considered
at
the
Meeting,
supported
the
Board’s
approval
of
the
continuation
of
the
Advisory
Contract.
Investment
Performance
of
the
Fund
The
Board
took
into
account
discussions
with
the
Adviser
and
detailed
reports
that
it
regularly
receives
throughout
the
year
on
relative
and
absolute
performance
for
the
T.
Rowe
Price
funds.
In
connection
with
the
Meeting,
the
Board
reviewed
information
provided
by
the
Adviser
that
compared
the
fund’s
total
returns,
as
well
as
a
wide
variety
of
other
previously
agreed-upon
performance
measures
and
market
data,
against
relevant
benchmark
indexes
and
peer
groups
of
funds
with
similar
investment
programs
for
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
various
periods
through
December
31,
2022. Additionally,
the
Board
reviewed
the
fund’s
relative
performance
information
as
of
September
30,
2022,
which
ranked
the
returns
of
the
fund’s
Investor
Class
for
various
periods
against
a
universe
of
funds
with
similar
investment
programs
selected
by
Broadridge,
an
independent
provider
of
mutual
fund
data.
In
the
course
of
its
deliberations,
the
Board
considered
performance
information
provided
throughout
the
year
and
in
connection
with
the
Advisory
Contract
review
at
the
Meeting,
as
well
as
information
provided
during
investment
review
meetings
conducted
with
portfolio
managers
and
senior
investment
personnel
during
the
course
of
the
year
regarding
the
fund’s
performance.
The
Board
also
considered
relevant
factors,
such
as
overall
market
conditions
and
trends
that
could
adversely
impact
the
fund’s
performance,
length
of
the
fund’s
performance
track
record,
and
how
closely
the
fund’s
strategies
align
with
its
benchmarks
and
peer
groups.
The
Board
concluded
that
the
information
it
considered
with
respect
to
the
fund’s
performance,
as
well
as
the
other
factors
considered
at
the
Meeting,
supported
the
Board’s
approval
of
the
continuation
of
the
Advisory
Contract.
Costs,
Benefits,
Profits,
and
Economies
of
Scale
The
Board
reviewed
detailed
information
regarding
the
revenues
received
by
the
Adviser
under
the
Advisory
Contract
and
other
direct
and
indirect
benefits
that
the
Adviser
(and
its
affiliates)
may
have
realized
from
its
relationship
with
the
fund.
In
considering
soft-
dollar
arrangements
pursuant
to
which
research
may
be
received
from
broker-dealers
that
execute
the
fund’s
portfolio
transactions,
the
Board
noted
that
the
Adviser
bears
the
cost
of
research
services
for
all
client
accounts
that
it
advises,
including
the
T.
Rowe
Price
funds.
The
Board
received
information
on
the
estimated
costs
incurred
and
profits
realized
by
the
Adviser
from
managing
the
T.
Rowe
Price
funds.
The
Board
also
reviewed
estimates
of
the
profits
realized
from
managing
the
fund
in
particular,
and
the
Board
concluded
that
the
Adviser’s
profits
were
reasonable
in
light
of
the
services
provided
to
the
fund.
The
Board
also
considered
whether
the
fund
benefits
under
the
fee
levels
set
forth
in
the
Advisory
Contract
or
otherwise
from
any
economies
of
scale
realized
by
the
Adviser.
Under
the
Advisory
Contract,
the
fund
pays
a
fee
to
the
Adviser
for
investment
management
services
composed
of
two
components—a
group
fee
rate
based
on
the
combined
average
net
assets
of
most
of
the
T.
Rowe
Price
funds
(including
the
fund)
that
declines
at
certain
asset
levels
and
an
individual
fund
fee
rate
based
on
the
fund’s
average
daily
net
assets—and
the
fund
pays
its
own
expenses
of
operations.
The
group
fee
rate
decreases
as
total
T.
Rowe
Price
fund
assets
grow,
which
reduces
the
management
fee
rate
for
any
fund
that
has
a
group
fee
component
to
its
management
fee,
and
reflects
that
certain
resources
utilized
to
operate
the
fund
are
shared
with
other
T.
Rowe
Price
funds
thus
allowing
shareholders
of
those
funds
to
share
potential
economies
of
scale.
The
fund’s
shareholders
also
benefit
from
potential
economies
of
scale
through
a
decline
in
certain
operating
expenses
as
the
fund
grows
in
size.
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
(continued)
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
In
addition,
the
Board
noted
that
the
fund
potentially
shares
in
indirect
economies
of
scale
through
the
Adviser’s
ongoing
investments
in
its
business
in
support
of
the
T.
Rowe
Price
funds,
including
investments
in
trading
systems,
technology,
and
regulatory
support
enhancements,
and
the
ability
to
possibly
negotiate
lower
fee
arrangements
with
third-
party
service
providers.
The
Board
concluded
that
the
advisory
fee
structure
for
the
fund
provides
for
a
reasonable
sharing
of
benefits
from
any
economies
of
scale
with
the
fund’s
investors.
Fees
and
Expenses
The
Board
was
provided
with
information
regarding
industry
trends
in
management
fees
and
expenses.
Among
other
things,
the
Board
reviewed
data
for
peer
groups
that
were
compiled
by
Broadridge,
which
compared:
(i)
contractual
management
fees,
actual
management
fees,
nonmanagement
expenses,
and
total
expenses
of
the
Investor
Class
of
the
fund
with
a
group
of
competitor
funds
selected
by
Broadridge
(Investor
Class
Expense
Group);
(ii)
actual
management
fees
and
total
expenses
of
the
Advisor
Class
of
the
fund
with
a
group
of
competitor
funds
selected
by
Broadridge
(Advisor
Class
Expense
Group);
and
(iii)
actual
management
fees,
nonmanagement
expenses,
and
total
expenses
of
the
Investor
Class
of
the
fund
with
a
broader
set
of
funds
within
the
Lipper
investment
classification
(Expense
Universe).
The
Board
considered
the
fund’s
contractual
management
fee
rate,
actual
management
fee
rate
(which
reflects
the
management
fees
actually
received
from
the
fund
by
the
Adviser
after
any
applicable
waivers,
reductions,
or
reimbursements),
operating
expenses,
and
total
expenses
(which
reflect
the
net
total
expense
ratio
of
the
fund
after
any
waivers,
reductions,
or reimbursements)
in
comparison
with
the
information
for
the
Broadridge
peer
groups.
Broadridge
generally
constructed
the
peer
groups
by
seeking
the
most
comparable
funds
based
on
similar
investment
classifications
and
objectives,
expense
structure,
asset
size,
and
operating
components
and
attributes
and
ranked
funds
into
quintiles,
with
the
first
quintile
representing
the
funds
with
the
lowest
relative
expenses
and
the
fifth
quintile
representing
the
funds
with
the
highest
relative
expenses.
The
information
provided
to
the
Board
indicated
that
the
fund’s
contractual
management
fee
ranked
in
the
first
quintile
(Investor
Class
Expense
Group),
the
fund’s
actual
management
fee
rate
ranked
in
the
first
quintile
(Investor
Class
Expense
Group,
Expense
Universe,
and
Advisor
Class
Expense
Group),
and
the
fund’s
total
expenses
ranked
in
the
first
quintile
(Investor
Class
Expense
Group,
Expense
Universe,
and
Advisor
Class
Expense
Group).
The
Board
also
reviewed
the
fee
schedules
for
other
investment
portfolios
with
similar
mandates
that
are
advised
or
subadvised
by
the
Adviser
and
its
affiliates,
including
separately
managed
accounts
for
institutional
and
individual
investors;
subadvised
funds;
and
other
sponsored
investment
portfolios,
including
collective
investment
trusts
and
pooled
vehicles
organized
and
offered
to
investors
outside
the
United
States.
Management
provided
the
Board
with
information
about
the
Adviser’s
responsibilities
and
services
provided
to
subadvisory
and
other
institutional
account
clients,
including
information
about
how
the
requirements
and
economics
of
the
institutional
business
are
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
(continued)
T.
ROWE
PRICE
Integrated
U.S.
Small-Cap
Growth
Equity
Fund
fundamentally
different
from
those
of
the
proprietary
mutual
fund
business.
The
Board
considered
information
showing
that
the
Adviser’s
mutual
fund
business
is
generally
more
complex
from
a
business
and
compliance
perspective
than
its
institutional
account
business
and
considered
various
relevant
factors,
such
as
the
broader
scope
of
operations
and
oversight,
more
extensive
shareholder
communication
infrastructure,
greater
asset
flows,
heightened
business
risks,
and
differences
in
applicable
laws
and
regulations
associated
with
the
Adviser’s
proprietary
mutual
fund
business.
In
assessing
the
reasonableness
of
the
fund’s
management
fee
rate,
the
Board
considered
the
differences
in
the
nature
of
the
services
required
for
the
Adviser
to
manage
its
mutual
fund
business
versus
managing
a
discrete
pool
of
assets
as
a
subadviser
to
another
institution’s
mutual
fund
or
for
an
institutional
account
and
that
the
Adviser
generally
performs
significant
additional
services
and
assumes
greater
risk
in
managing
the
fund
and
other
T.
Rowe
Price
funds
than
it
does
for
institutional
account
clients,
including
subadvised
funds.
On
the
basis
of
the
information
provided
and
the
factors
considered,
the
Board
concluded
that
the
fees
paid
by
the
fund
under
the
Advisory
Contract
are
reasonable.
Approval
of
the
Advisory
Contract
As
noted,
the
Board
approved
the
continuation
of
the
Advisory
Contract.
No
single
factor
was
considered
in
isolation
or
to
be
determinative
to
the
decision.
Rather,
the
Board
concluded,
in
light
of
a
weighting
and
balancing
of
all
factors
considered,
that
it
was
in
the
best
interests
of
the
fund
and
its
shareholders
for
the
Board
to
approve
the
continuation
of
the
Advisory
Contract
(including
the
fees
to
be
charged
for
services
thereunder).
APPROVAL
OF
INVESTMENT
MANAGEMENT
AGREEMENT
(continued)
100
East
Pratt
Street
Baltimore,
MD
21202
T.
Rowe
Price
Investment
Services,
Inc.
Call
1-800-225-5132
to
request
a
prospectus
or
summary
prospectus;
each
includes
investment
objectives,
risks,
fees,
expenses,
and
other
information
that
you
should
read
and
consider
carefully
before
investing.
F120-051
8/23
Item 1. (b) Notice pursuant to Rule 30e-3.
Not applicable.
Item 2. Code of Ethics.
A code of ethics, as defined in Item 2 of Form N-CSR, applicable to its principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions is filed as an exhibit to the registrant’s annual Form N-CSR. No substantive amendments were approved or waivers were granted to this code of ethics during the registrant’s most recent fiscal half-year.
Item 3. Audit Committee Financial Expert.
Disclosure required in registrant’s annual Form N-CSR.
Item 4. Principal Accountant Fees and Services.
Disclosure required in registrant’s annual Form N-CSR.
Item 5. Audit Committee of Listed Registrants.
Not applicable.
Item 6. Investments.
(a) Not applicable. The complete schedule of investments is included in Item 1 of this Form N-CSR.
(b) Not applicable.
Item 7. Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.
Not applicable.
Item 8. Portfolio Managers of Closed-End Management Investment Companies.
Not applicable.
Item 9. Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.
Not applicable.
Item 10. Submission of Matters to a Vote of Security Holders.
There has been no change to the procedures by which shareholders may recommend nominees to the registrant’s board of directors.
Item 11. Controls and Procedures.
(a) The registrant’s principal executive officer and principal financial officer have evaluated the registrant’s disclosure controls and procedures within 90 days of this filing and have concluded that the registrant’s disclosure controls and procedures were effective, as of that date, in ensuring that information required to be disclosed by the registrant in this Form N-CSR was recorded, processed, summarized, and reported timely.
(b) The registrant’s principal executive officer and principal financial officer are aware of no change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
Item 12. Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.
Not applicable.
Item 13. Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | | | |
| T. Rowe Price Integrated Equity Funds, Inc. |
| | |
| By | | /s/ David Oestreicher | | |
| | David Oestreicher | | |
| | Principal Executive Officer | | |
| | |
| Date | | August 18, 2023 | | |
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| | | | |
| By | | /s/ David Oestreicher | | |
| | David Oestreicher | | |
| | Principal Executive Officer | | |
| | |
| Date | | August 18, 2023 | | |
| | |
| By | | /s/ Alan S. Dupski | | |
| | Alan S. Dupski | | |
| | Principal Financial Officer | | |
| | |
| Date | | August 18, 2023 | | |
